Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
69000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an option to amend the exercise price)
Who receives how much
Shares delivered since the previous disclosure: 69,000 shares (69,000 new shares; no treasury shares transferred)
Cantor Fitzgerald Europe (allottee of the Series 16 Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
Exercise price: ¥764. Details of the adjustment provisions and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 6,515; unexercised at the time of the previous disclosure: 5,342; currently unexercised: 4,652
Most recent equity financing
Timing 26 December 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights (with an Option to Revise the Exercise Price) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an option to amend the exercise price) |
| Number of shares to be issued or disposed of | Shares delivered since the previous disclosure: 69,000 shares (69,000 new shares; no treasury shares transferred) |
| Intended allottee | Cantor Fitzgerald Europe (allottee of the Series 16 Stock Acquisition Rights) |
| Total number of issued shares | 8,394,800 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Exercise price | Exercise price: ¥764. Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 6,515; unexercised at the time of the previous disclosure: 5,342; currently unexercised: 4,652 |
| Most recent equity financing | Timing 26 December 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights (with an Option to Revise the Exercise Price) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide notice of the mass exercise of these Stock Acquisition Rights on 3 April 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.